TimothyCRodellMD

PubMed

• Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis
  Carolina Boni, Harry L.A. Janssen, Marzia Rossi, Seung Kew Yoon, Andrea Vecchi, Valeria Barili, Eric M. Yoshida, Huy N. Trinh, Timothy C. Rodell, Diletta Laccabue, Ari...> ;Gastroenterology. 2019 Jul 1
• Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial.
  Allen Lee Cohn, Michael A. Morse, Bert H. O'Neil, Samuel Whiting, Claire Coeshott, John Ferraro, Donald Bellgrau, David Apelian, Timothy C. Rodell> ;Journal of Immunotherapy. 2018 Apr 1
• GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.
  King, T. H., Shanley, C. A., Guo, Z., Bellgrau, D., Rodell, T. C., Furney, S. K., Henao-Tamayo, M., Orme, I. M.> ;Clinical and vaccine immunology : CVI. 2017 Oct 20
• Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B.
  Lok, A. S., Pan, C. Q., Han, S. B., Trinh, H. N., Fessel, W. J., Rodell, T. C., Massetto, B., Lin, L., Gaggar, A., Subramanian, G. M., McHutchison, J. G., Ferrari, C.,...> ;Journal of hepatology. 2016 May 24
• Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines.
  King, T. H., Guo, Z., Hermreck, M., Bellgrau, D., Rodell, T. C.> ;Methods in molecular biology (Clifton, N.J.). 2016 Apr 15
• 22 citations
  Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
  Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst, Jennifer L. Marte, Renee N. Donahue, Italia Grenga, Timothy C. Rodell, William L. Dahut, Philip M. Arlen, Ra...> ;Cancer immunology research. 2015 Jun 30
• 11 citations
  Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition a...
  Tucker, J. A., Jochems, C., Boyerinas, B., Fallon, J., Greiner, J. W., Palena, C., Rodell, T. C., Schlom, J., Tsang, K.> ;Cancer immunology, immunotherapy : CII. 2014 Sep 5
• Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study
  Anuj Gaggar, Claire Coeshott, David Apelian, Timothy C. Rodell, Brian R. Armstrong, Gong Shen, G. Mani Subramanian, John G. McHutchison> ;Vaccine. 2014 Sep 3
• 17 citations
  A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral...
  Thomas H. King, Charles B. Kemmler, Zhimin Guo, Derrick Mann, Yingnian Lu, Claire Coeshott, Adam J. Gehring, Antonio Bertoletti, Zi Z. Ho, William E. Delaney, Anuj Gag...> ;PLOS ONE. 2014 Jul 22
• 41 citations
  A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
  David M. Hockenbery, Scott Cruickshank, Timothy C. Rodell, Ted Gooley, Friedrich Schuening, Scott D. Rowley, Donald S. David, Mark W. Brunvand, Brian Berryman, Sunil A...> ;Blood. 2007 May 15
• Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins
  Aurelia Haller, Georg M. Lauer, Thomas H. King, Charles B. Kemmler, Valerie Fiolkoski, Yingnian Lu, Don Bellgrau, Timothy C. Rodell, David Apelian, Alex Franzusoff, Ri...> ;Vaccine. 2007 Feb 9
• Mutation-Selective Tumor Remission with Ras-Targeted, Whole Yeast-Based Immunotherapy
  Yingnian Lu, Donald Bellgrau, Lori D. Dwyer-Nield, Alvin M. Malkinson, Richard C. Duke, Timothy C. Rodell, Alex Franzusoff> ;Cancer Research. 2004 Aug 1
• Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, ...
  Alan M. Fein, Gordon R. Bernard, Gerard J. Criner, Eugene C. Fletcher, James T. Good, William A. Knaus, Howard Levy, George M. Matuschak, Harvey M. Shanies, Robert W. ...> ;JAMA. 1997 Feb 12
• The kallikrein/kinin system and kinin antagonists in trauma
  Timothy C. Rodell> ;Immunopharmacology. 1996 Jun 1
• Pulmonary Oxygen Toxicity and Ischemia-Reperfusion Injury: A Mechanism in Common Involving Xanthine Oxidase and Neutrophils
  John E. Repine, J. C. Cheronis, Timothy C. Rodell, Stuart L. Linas, Anita Patt> ;The American review of respiratory disease. 1987 Aug 1
• Wilms' tumor-aniridia association: Segregation of affected chromosome in somatic cell hybrids, identification of cell surface antigen associated with deleted area, and...
  James H. Fisher, York E. Miller, Robert S. Sparkes, J. Brownwyn Bateman, Kathryn A. Kimmel, Thomas E. Carey, Timothy Rodell, Steven A. Shoemaker, Charles H. Scoggin> ;Somatic Cell and Molecular Genetics. 1984 Sep 1
• Traumatic brain contusions: a clinical role for the kinin antagonist CP-0127.
  Narotam, P. K., Rodell, T. C., Nadvi, S. S., Bhoola, K. D., Troha, J. M., Parbhoosingh, R., van Dellen, J. R.> ;Acta Neurochir (Wien). 1998
• Endothelial cell xanthine oxidase-derived toxic oxygen metabolites contribute to acute lung injury from neutrophil elastase.
  Rodell, T. C., Cheronis, J. C., Repine, J. E.> ;Chest. 1988 Mar
• Xanthine oxidase-derived hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil brains.
  Patt, A., Harken, A. H., Burton, L. K., Rodell, T. C., Piermattei, D., Schorr, W. J., Parker, N. B., Berger, E. M., Horesh, I. R., Terada, L. S.> ;J Clin Invest. 1988 May
• Xanthine oxidase mediates elastase-induced injury to isolated lungs and endothelium.
  Rodell, T. C., Cheronis, J. C., Ohnemus, C. L., Piermattei, D. J., Repine, J. E.> ;J Appl Physiol. 1987 Nov
• Join now to see all